Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 19 Mar 21 424B4 Prospectus supplement with pricing info
- 19 Mar 21 EFFECT Notice of effectiveness
- 18 Mar 21 F-1/A Registration statement (foreign) (amended)
- 17 Mar 21 F-1/A Registration statement (foreign) (amended)
- 12 Mar 21 F-1/A Registration statement (foreign) (amended)
-
26 Feb 21 F-1 Registration statement (foreign)
CNTB similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form F-1 of Connect Biopharma Holdings Limited of our report dated February 26, 2021 relating to the financial statements of Connect Biopharma Holdings Limited, which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers Zhong Tian LLP
Beijing, the People’s Republic of China
February 26, 2021